Search

Background: Human immunodeficiency virus (HIV) and tuberculosis (TB) coinfection represents a serious public health problem that requires new approaches for its prevention and comprehensive management. Therefore, the aim of this study was to analyze the bibliometric profile of the worldwide scientific production on TB and HIV coinfection., Methods: Bibliometric study that retrieved publications indexed in Scopus, from the design of a search strategy based on Medical Subject Heading terms and logical operators. The sample consisted of 219 articles, whose metadata were analyzed with SciVal, VOSviewer, and RStudio., Results: Between 2017 and 2018, there was a notorious interest in the interrelationship between HIV and TB, as well as in the role of Mycobacterium tuberculosis in the context of acquired immunodeficiency syndrome. The United States and South Africa clustered the most publications. On the other hand, the most productive authors have a US Institution affiliation, Brust James CM and Gandhi Neel R had seven publications. The categories of "Infectious Diseases" and "Microbiology (medical)" accumulated 94 and 35 publications. In addition, the most productive journals were PLOS One and the International Journal of TB and Lung Disease, while clinical infectious diseases had the best CiteScore 2021 (17.3)., Conclusions: Scientific production has been mainly disseminated in high-impact journals, with a slight increase in recent years. The United States is the leading and most influential country, followed by South Africa; in addition, Brust James CM, an American National, is recognized as the most productive., Competing Interests: None

Background: The increase in the number of pregnant women with tuberculosis is an important factor that should be analyzed at present. Thus, It is important to evaluate the bibliometric characteristics of the scientific production indexed in Scopus on complications of pregnancy and childbirth in pregnant women with tuberculosis., Methods: A cross-sectional bibliometric study was carried out analyzing the publications of journals indexed in Scopus between January 2016 and May 2022. A search strategy was developed using MESH terms and Boolean operators. The SciVal program (Elsevier) was used for bibliometric analysis of the information in the documents., Results: Of the 287 publications analyzed, 13 were in the International Journal of Tuberculosis and Lung Disease and BJOG: An International Journal of Obstetrics and Gynaecology presented 11.9 citations per publication. Gupta Amita, from the United States, presented the most published papers; however, Myer London, from South Africa, had the highest impact, with 17.8 citations per publication. Johns Hopkins University was the institution with the highest number of publications (34). 51.9% of the publications were in journals in the Q1 quartile while 41.8% were international collaborations., Conclusions: In each year analyzed, scientific production was similar, with the highest proportion of publications in journals located in the Q1 and Q2 quartile. The institutions with the highest production were from the United States and South Africa. Therefore, there is a need to promote collaborative production in countries with greater presence of this disease., Competing Interests: None

Background: Tuberculosis is one of the leading causes of death worldwide affecting mainly low- and middle-income countries. Therefore, the objective is to analyze the bibliometric characteristics of the application of artificial intelligence (AI) in tuberculosis in Scopus., Methods: A bibliometric study, the Scopus database was used using a search strategy composed of controlled and free terms regarding tuberculosis and AI. The search fields "TITLE," "ABSTRACT," and "AUTHKEY" were used to find the terms. The collected data were analyzed with Scival software. Bibliometric data were described through the figures and tables summarized by absolute values and percentages., Results: Thousand and forty-one documents were collected and analyzed. Yudong Zhang was the author with the highest scientific production; however, K. C. Santosh had the greatest impact. Anna University (India) was the institution with the highest number of published papers. Most papers were published in the first quartile. The United States led the scientific production. Articles with international collaboration had the highest impact., Conclusion: Articles related to tuberculosis and AI are mostly published in first quartile journals, which would reflect the need and interest worldwide. Although countries with a high incidence of new cases of tuberculosis are among the most productive, those with the highest reported drug resistance need greater support and collaboration., Competing Interests: None

Background: Nowadays, tuberculosis and COVID-19 are the principal infections around the world. This study aimed to determine the global scientific production on COVID-19 associated to tuberculosis during the period 2019-2020., Methods: For the collection of metadata on COVID-19 associated to tuberculosis, the Scopus database was used, considering the period 2019-2020, with the last day of update being September 13, 2021. The main authors, countries, institutions, journal metrics, and documents were extracted. The Scival tool was used for the scientometric analysis of the data., Results: A total of 464 papers were retrieved where it was found that universities in South Africa, the United States, and England led the world's scientific production. The International Journal of Tuberculosis and Lung Disease was the journal with the highest production and The Lancet Global Health was the journal with the most citations per publication. On the other hand, most papers were published in Q1 journals, with infectious diseases within the area of medicine being the most addressed., Conclusion: South African universities lead the world in scientific output. Most of the research on this topic has been published in Q1 journals, with collaboration being largely national. Further analysis is needed in the aftermath of the pandemic., Competing Interests: None